Leukocyte transmigration across the blood-brain barrier: Perspectives on neuroAIDS

Toni Kay Roberts, Clarisa Michelle Buckner, Joan W. Berman

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Leukocyte trafficking serves a critical function in central nervous system (CNS) immune surveillance. However, in many disease states leukocyte entry into the CNS is increased, which can disrupt the blood-brain barrier (BBB) and propagate neuroinflammation. These pathologic processes result in BBB permeability, glial activation, and neuronal compromise, all of which contribute to CNS damage. The resulting neuronal injury and loss are characteristic of many neuroinflammatory conditions including Alzheimer disease, multiple sclerosis, HIV-1 encephalopathy, sepsis, ischemia and reperfusion, and CNS tumors. HIV-1 encephalopathy is unique among these processes in that viral activity exacerbates CNS immune dysregulation and promotes chronic neuroinflammation and neurodegeneration. Thus, a significant number of HIV-1-infected persons exhibit neurocognitive and/or motor impairment. This review discusses the mechanisms that regulate leukocyte recruitment into the CNS and how HIV-1 infection dysregulates this process and contributes to neuropathology. Experimental BBB models to study leukocyte transmigration and the potential of targeting this transmigration across the BBB as a therapeutic strategy are also discussed.

Original languageEnglish (US)
Pages (from-to)478-536
Number of pages59
JournalFrontiers in Bioscience
Volume15
Issue number2
DOIs
StatePublished - Jan 1 2010

Fingerprint

Neurology
Blood-Brain Barrier
Leukocytes
Central Nervous System
HIV-1
AIDS Dementia Complex
Central Nervous System Neoplasms
Pathologic Processes
Neuroglia
Multiple Sclerosis
Reperfusion
HIV Infections
Permeability
Sepsis
Alzheimer Disease
Ischemia
Neuroaid
Tumors
Chemical activation
Wounds and Injuries

Keywords

  • Adhesion molecules
  • Blood-Brain Barrier
  • CCL2
  • Diapedesis
  • HIV-1
  • Leukocytes
  • Monocytes
  • NeuroAIDS
  • Paracellular Migration
  • Review
  • Therapeutics
  • Transcellular migration
  • Transmigration

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Leukocyte transmigration across the blood-brain barrier : Perspectives on neuroAIDS. / Roberts, Toni Kay; Buckner, Clarisa Michelle; Berman, Joan W.

In: Frontiers in Bioscience, Vol. 15, No. 2, 01.01.2010, p. 478-536.

Research output: Contribution to journalArticle

Roberts, Toni Kay ; Buckner, Clarisa Michelle ; Berman, Joan W. / Leukocyte transmigration across the blood-brain barrier : Perspectives on neuroAIDS. In: Frontiers in Bioscience. 2010 ; Vol. 15, No. 2. pp. 478-536.
@article{0f0656c3cafc4b8eaeb72df61f5d203c,
title = "Leukocyte transmigration across the blood-brain barrier: Perspectives on neuroAIDS",
abstract = "Leukocyte trafficking serves a critical function in central nervous system (CNS) immune surveillance. However, in many disease states leukocyte entry into the CNS is increased, which can disrupt the blood-brain barrier (BBB) and propagate neuroinflammation. These pathologic processes result in BBB permeability, glial activation, and neuronal compromise, all of which contribute to CNS damage. The resulting neuronal injury and loss are characteristic of many neuroinflammatory conditions including Alzheimer disease, multiple sclerosis, HIV-1 encephalopathy, sepsis, ischemia and reperfusion, and CNS tumors. HIV-1 encephalopathy is unique among these processes in that viral activity exacerbates CNS immune dysregulation and promotes chronic neuroinflammation and neurodegeneration. Thus, a significant number of HIV-1-infected persons exhibit neurocognitive and/or motor impairment. This review discusses the mechanisms that regulate leukocyte recruitment into the CNS and how HIV-1 infection dysregulates this process and contributes to neuropathology. Experimental BBB models to study leukocyte transmigration and the potential of targeting this transmigration across the BBB as a therapeutic strategy are also discussed.",
keywords = "Adhesion molecules, Blood-Brain Barrier, CCL2, Diapedesis, HIV-1, Leukocytes, Monocytes, NeuroAIDS, Paracellular Migration, Review, Therapeutics, Transcellular migration, Transmigration",
author = "Roberts, {Toni Kay} and Buckner, {Clarisa Michelle} and Berman, {Joan W.}",
year = "2010",
month = "1",
day = "1",
doi = "10.2741/3631",
language = "English (US)",
volume = "15",
pages = "478--536",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "2",

}

TY - JOUR

T1 - Leukocyte transmigration across the blood-brain barrier

T2 - Perspectives on neuroAIDS

AU - Roberts, Toni Kay

AU - Buckner, Clarisa Michelle

AU - Berman, Joan W.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Leukocyte trafficking serves a critical function in central nervous system (CNS) immune surveillance. However, in many disease states leukocyte entry into the CNS is increased, which can disrupt the blood-brain barrier (BBB) and propagate neuroinflammation. These pathologic processes result in BBB permeability, glial activation, and neuronal compromise, all of which contribute to CNS damage. The resulting neuronal injury and loss are characteristic of many neuroinflammatory conditions including Alzheimer disease, multiple sclerosis, HIV-1 encephalopathy, sepsis, ischemia and reperfusion, and CNS tumors. HIV-1 encephalopathy is unique among these processes in that viral activity exacerbates CNS immune dysregulation and promotes chronic neuroinflammation and neurodegeneration. Thus, a significant number of HIV-1-infected persons exhibit neurocognitive and/or motor impairment. This review discusses the mechanisms that regulate leukocyte recruitment into the CNS and how HIV-1 infection dysregulates this process and contributes to neuropathology. Experimental BBB models to study leukocyte transmigration and the potential of targeting this transmigration across the BBB as a therapeutic strategy are also discussed.

AB - Leukocyte trafficking serves a critical function in central nervous system (CNS) immune surveillance. However, in many disease states leukocyte entry into the CNS is increased, which can disrupt the blood-brain barrier (BBB) and propagate neuroinflammation. These pathologic processes result in BBB permeability, glial activation, and neuronal compromise, all of which contribute to CNS damage. The resulting neuronal injury and loss are characteristic of many neuroinflammatory conditions including Alzheimer disease, multiple sclerosis, HIV-1 encephalopathy, sepsis, ischemia and reperfusion, and CNS tumors. HIV-1 encephalopathy is unique among these processes in that viral activity exacerbates CNS immune dysregulation and promotes chronic neuroinflammation and neurodegeneration. Thus, a significant number of HIV-1-infected persons exhibit neurocognitive and/or motor impairment. This review discusses the mechanisms that regulate leukocyte recruitment into the CNS and how HIV-1 infection dysregulates this process and contributes to neuropathology. Experimental BBB models to study leukocyte transmigration and the potential of targeting this transmigration across the BBB as a therapeutic strategy are also discussed.

KW - Adhesion molecules

KW - Blood-Brain Barrier

KW - CCL2

KW - Diapedesis

KW - HIV-1

KW - Leukocytes

KW - Monocytes

KW - NeuroAIDS

KW - Paracellular Migration

KW - Review

KW - Therapeutics

KW - Transcellular migration

KW - Transmigration

UR - http://www.scopus.com/inward/record.url?scp=77951216287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951216287&partnerID=8YFLogxK

U2 - 10.2741/3631

DO - 10.2741/3631

M3 - Article

C2 - 20036831

AN - SCOPUS:77951216287

VL - 15

SP - 478

EP - 536

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - 2

ER -